Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase Santyl vs Bacitracin for Minor Burns
NCT01516463Phase 4Withdrawn
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Mar 2012
- Primary completion
- Jun 2013
- Modality
- Therapeutic Enzymes
01
Overview
A Phase 4 trial of collagenase in partial-thickness burn, sponsored by Healthpoint Biotherapeutics. Planned start Mar 2012; status: withdrawn.
02
Drugs
collagenase
03
Conditions
partial-thickness burn
Beyond the preview
Go deeper on NCT01516463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516463.